January 29, 2013
"Hepatitis C: Present Management and Future Directions"
Ira Jacobson, MD
Chief of the Division of Gastroenterology and Hepatology
Vincent Astor Distinguished Professor of Medicine
The Joan Sanford I. Weill Medical College of Cornell University
Dr. Jacobson reviewed the history of treatment of chronic hepatitis C and, specifically, the role of interferon (IFN) and ribavirin as cornerstones of therapy for the past twenty years. He spent the remainder of his time noting the recent landmark studies showing improved cure, or sustained virologic response (SVR), with new protease inhibitors combined with IFN and ribavirin as well as shortened duration of treatment. He also noted recent studies showing promise with new agents that are non-inferior to current optimal therapy and may obviate the need for IFN/ribavirin-based therapies and the general optimism that a cure hepatitis C may soon be widely attainable.
View Presentation-
http://medicine.med.nyu.edu/education/grand-rounds/mgr-ira-jacobson-md-video
Related - Watch: Hepatitis C Management - Professor Ira M Jacobson
No comments:
Post a Comment